245 related articles for article (PubMed ID: 35132719)
1. The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome.
Cooze BJ; Dickerson M; Loganathan R; Watkins LM; Grounds E; Pearson BR; Bevan RJ; Morgan BP; Magliozzi R; Reynolds R; Neal JW; Howell OW
Brain Pathol; 2022 Sep; 32(5):e13054. PubMed ID: 35132719
[TBL] [Abstract][Full Text] [Related]
2. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
Magliozzi R; Fadda G; Brown RA; Bar-Or A; Howell OW; Hametner S; Marastoni D; Poli A; Nicholas R; Calabrese M; Monaco S; Reynolds R
Ann Neurol; 2022 Oct; 92(4):670-685. PubMed ID: 35748636
[TBL] [Abstract][Full Text] [Related]
3. Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Watkins LM; Neal JW; Loveless S; Michailidou I; Ramaglia V; Rees MI; Reynolds R; Robertson NP; Morgan BP; Howell OW
J Neuroinflammation; 2016 Jun; 13(1):161. PubMed ID: 27333900
[TBL] [Abstract][Full Text] [Related]
4. Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.
Evans R; Watkins LM; Hawkins K; Santiago G; Demetriou C; Naughton M; Dittmer M; Rees MI; Fitzgerald D; Morgan BP; Neal JW; Howell OW
Front Cell Neurosci; 2023; 17():1094106. PubMed ID: 37032838
[TBL] [Abstract][Full Text] [Related]
5. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.
Howell OW; Schulz-Trieglaff EK; Carassiti D; Gentleman SM; Nicholas R; Roncaroli F; Reynolds R
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):798-813. PubMed ID: 25421634
[TBL] [Abstract][Full Text] [Related]
6. In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology.
De Meo E; Storelli L; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
Brain; 2021 Feb; 144(1):186-197. PubMed ID: 33221873
[TBL] [Abstract][Full Text] [Related]
7. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
8. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.
Magliozzi R; Howell OW; Durrenberger P; Aricò E; James R; Cruciani C; Reeves C; Roncaroli F; Nicholas R; Reynolds R
J Neuroinflammation; 2019 Dec; 16(1):259. PubMed ID: 31810488
[TBL] [Abstract][Full Text] [Related]
9. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
Loveless S; Neal JW; Howell OW; Harding KE; Sarkies P; Evans R; Bevan RJ; Hakobyan S; Harris CL; Robertson NP; Morgan BP
Brain Pathol; 2018 Jul; 28(4):507-520. PubMed ID: 28707765
[TBL] [Abstract][Full Text] [Related]
10. Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.
Harrison DM; Oh J; Roy S; Wood ET; Whetstone A; Seigo MA; Jones CK; Pham D; van Zijl P; Reich DS; Calabresi PA
Mult Scler; 2015 Aug; 21(9):1139-50. PubMed ID: 25583851
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter.
Picon C; Jayaraman A; James R; Beck C; Gallego P; Witte ME; van Horssen J; Mazarakis ND; Reynolds R
Acta Neuropathol; 2021 Apr; 141(4):585-604. PubMed ID: 33569629
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.
Mahajan KR; Nakamura K; Cohen JA; Trapp BD; Ontaneda D
Ann Neurol; 2020 Jul; 88(1):81-92. PubMed ID: 32286701
[TBL] [Abstract][Full Text] [Related]
13. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
Bevan RJ; Evans R; Griffiths L; Watkins LM; Rees MI; Magliozzi R; Allen I; McDonnell G; Kee R; Naughton M; Fitzgerald DC; Reynolds R; Neal JW; Howell OW
Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156
[TBL] [Abstract][Full Text] [Related]
14. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi SR; Howell OW; Carassiti D; Magliozzi R; Gveric D; Muraro PA; Nicholas R; Roncaroli F; Reynolds R
Brain; 2012 Oct; 135(Pt 10):2925-37. PubMed ID: 22907116
[TBL] [Abstract][Full Text] [Related]
15. Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis.
Romanò F; Motl RW; Valsasina P; Amato MP; Brichetto G; Bruschi N; Chataway J; Chiaravalloti ND; Cutter G; Dalgas U; DeLuca J; Farrell R; Feys P; Freeman J; Inglese M; Meza C; Salter A; Sandroff BM; Feinstein A; Rocca MA; Filippi M;
J Neurol; 2023 Jun; 270(6):3213-3224. PubMed ID: 36933030
[TBL] [Abstract][Full Text] [Related]
16. Progression of regional grey matter atrophy in multiple sclerosis.
Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
Kalinin I; Makshakov G; Evdoshenko E
AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
[TBL] [Abstract][Full Text] [Related]
18. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
[TBL] [Abstract][Full Text] [Related]
19. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Haider L; Simeonidou C; Steinberger G; Hametner S; Grigoriadis N; Deretzi G; Kovacs GG; Kutzelnigg A; Lassmann H; Frischer JM
J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1386-95. PubMed ID: 24899728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
